Suncoast Equity Management Invests $694,000 in HealthEquity, Inc. $HQY

Suncoast Equity Management acquired a new stake in HealthEquity, Inc. (NASDAQ:HQY) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 7,320 shares of the company’s stock, valued at approximately $694,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HQY. Farther Finance Advisors LLC grew its stake in HealthEquity by 232.4% during the 2nd quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after acquiring an additional 172 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in shares of HealthEquity in the second quarter valued at approximately $33,000. True Wealth Design LLC increased its holdings in shares of HealthEquity by 3,522.2% in the third quarter. True Wealth Design LLC now owns 326 shares of the company’s stock valued at $31,000 after purchasing an additional 317 shares during the last quarter. Cullen Frost Bankers Inc. lifted its position in HealthEquity by 172.3% during the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after buying an additional 224 shares in the last quarter. Finally, Sellwood Investment Partners LLC purchased a new position in HealthEquity during the second quarter worth approximately $58,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on HQY shares. BTIG Research reaffirmed a “buy” rating and issued a $130.00 target price on shares of HealthEquity in a research note on Thursday, December 4th. Citigroup reiterated an “outperform” rating on shares of HealthEquity in a report on Thursday, December 4th. JPMorgan Chase & Co. increased their price target on shares of HealthEquity from $126.00 to $129.00 and gave the company an “overweight” rating in a research note on Thursday, December 4th. KeyCorp reduced their price target on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $120.27.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the sale, the executive vice president directly owned 49,795 shares in the company, valued at $4,392,416.95. This represents a 3.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the transaction, the executive vice president directly owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. The trade was a 1.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 17,240 shares of company stock valued at $1,640,164 in the last three months. 1.50% of the stock is owned by corporate insiders.

HealthEquity Stock Performance

NASDAQ:HQY opened at $91.61 on Friday. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. The company has a 50 day moving average price of $97.03 and a 200 day moving average price of $95.52. The stock has a market capitalization of $7.83 billion, a P/E ratio of 42.02, a PEG ratio of 1.32 and a beta of 0.20.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The company had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. During the same quarter in the previous year, the company earned $0.78 earnings per share. The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities research analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.